How can we empower patients to take control of their #osteoarthritis? Dr Dawn Richards @TO_dpr shares her experience living with arthritis and discusses this very important topic in this week’s episode. Listen at https://t.co/WguQBhfw2d
In July 2021, NAMSA announced its accreditation to the FDA’s first-ever #ASCA Pilot Program for #biocompatibility testing. Access our on-demand webinar to learn about this program and explore the advantages of working with an ASCA-accredited laboratory. https://t.co/iuY36kjCS4
New BiocompCHATibility episode! Join our hosts, alongside guest Michelle Kelly, as they discuss maintaining the balance of the risk and benefit of a medical device without stalling innovation, as well as the challenges of the biological equivalency claim. https://t.co/zWVV1ZMrxg
The EIC Rising Women Innovator 2021 prize, has been granted to Ailbhe and Isabel Keane from Ireland, founders of Izzy Wheels. Their company creates fashionable wheel covers for wheelchairs. Congratulations! @izzywheels@DeptEnterprise@DeptEnterprise@EI_HPSU@Entirl@izzywheels
Up next, we are going to explore ‘What new partnerships, innovation and collaboration models are developing in Ireland?’ Please welcome Martin O’Halloran @BioInnovate_Ire, Dr. Brendan Boland @lociortho, Dr. Tanya Mulcahy @HIHIreland &
John Kelly @wearetuhf#HealthTech21
What a wonderful #RiDaysEU!
Now we have learnt from the past, let's shape our future together.✨
We need to support our #researchers#innovators & #universities and cooperate w/ MS, regions, 🇪🇺 citizens & #younger generations.🔬🎓
Thanks to all of you for contributing! 👏
International Day of Women and Girls in Science is celebrating #WomenInScience at the forefront of the fight against COVID-19 such as Prof Zena Moore at @RCSI_Irl , with her research under the COVID-19 Rapid Response Research and Innovation call @UN_Women
Resource requirements for reintroducing #elective#surgery during #COVID19 pandemic 🌐
❌ 800k estimated procedures cancelled by May 2020
🕰️ 2 millions patients waiting surgery at February 2021
💵 cost delayed procedures €5.3 billions
Free full text 🔗
https://t.co/ylo6HiZjoG
Great to see that Loci Orthopaedics was selected as one of the top 5 startups developing innovative orthopaedic devices, after a review of 187 relevant solutions https://t.co/49c5ps7m4t
The global medical device landscape is complex, and getting a new product or therapy approved requires compelling clinical evidence. NAMSA’s broad range of experience allows us to lead clients through all phases of #clinicalresearch. Learn more: https://t.co/n1955kKxve
#medtech